| MOPEC01 | Race, place, and substance use continue to impact HIV incidence among Sexual Minority Men: active surveillance of HIV seroconversion from the UNITE Longitudinal Cohort study | Poster exhibition | Epidemiology of HIV |
| MOPEB21 | Disability in people living with HIV (PLWH) in Asia: a prospective multi-centre case-control study | Poster exhibition | HIV and ageing |
| MOPEB20 | Sedative drug burden is associated with concurrent physical frailty in people aging with HIV in Canada: findings from the Positive Brain Health Now Study (+BHN) | Poster exhibition | HIV and ageing |
| MOPEB19 | Weight gain among people living with HIV in Zambia transitioning to dolutegravir-based antiretroviral regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate | Poster exhibition | Clinical complications of HIV and antiretroviral therapy |
| MOPEB18 | A randomized controlled trial of (5R)-5-hydroxytriptolide in HIV INRs receiving ART | Poster exhibition | Clinical complications of HIV and antiretroviral therapy |
| MOPEB17 | Renal safety parameters after switch to doravirine/islatravir (DOR/ISL 100/0.75mg) once-daily: week 48 results from 2 randomized, active-controlled phase 3 trials, MK8591A-017 (P017) and MK8591A-018 (P018) | Poster exhibition | Clinical complications of HIV and antiretroviral therapy |
| MOPEB16 | Association between HIV-related factors and hypertension and diabetes among people living with HIV in Cameroon | Poster exhibition | Co-morbidities |
| MOPEB15 | Bone mineral density changes in postpartum mothers living with HIV on antiretroviral therapy | Poster exhibition | Co-morbidities |
| MOPEB14 | Accuracy of a new PHQ-9 scoring algorithm to screen for depression in PLHIV cohorts in Sub-Saharan Africa | Poster exhibition | Co-morbidities |
| MOPEB13 | Association between non-alcohol steatohepatitis with significant activity and fibrosis and neurocognitive impairment in people with HIV | Poster exhibition | Co-morbidities |